Artificial tears
FDA Approved
Description
Artificial tears are lubricating eye drops used to relieve dryness and irritation of the ocular surface. They are commonly used in corneal dystrophies to maintain corneal hydration and reduce discomfort. These products provide symptomatic relief and help protect the corneal epithelium.
Indications & Therapeutic Use
Dry eye syndrome, corneal dystrophies, ocular surface disorders
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Artificial tears
| Generic Name | Artificial tears |
| Brands | 1 brand available |
| Active Ingredient | Polyethylene glycol 400, Propylene glycol |
| Drug Class | Dry eye syndrome |
| Manufacturer | Alcon |
| Dosage Forms | Ophthalmic solution 0.4%/0.3%; Preservative-free single-use vials |
| Medical Code | S01XA20 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes